Doctor Masakazu Miyamoto

Okayama University Hospital, Okayama (Japan)

Follow

Contributor content

Efficacy of early intravenous landiolol, an ultrashort-acting beta-blocker on infarct size and its safety in patients with myocardial infarction undergoing primary PCI: a randomized, controlled study

Presentation

Efficacy of early intravenous landiolol, an ultrashort-acting beta-blocker on infarct size and its safety in patients with myocardial infarction undergoing primary PCI: a randomized, controlled study

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources